Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study

Jurjen Versluis, Wael Saber, Harrison K. Tsai, Christopher J. Gibson, Laura W. Dillon, Asmita Mishra, Joseph McGuirk, Richard T. Maziarz, Peter Westervelt, Pranay Hegde, Devdeep Mukherjee, Michael J. Martens, Brent Logan, Mary Horowitz, Christopher S. Hourigan, Ryotaro Nakamura, Corey Cutler, R. Coleman Lindsley

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study'. Together they form a unique fingerprint.

Medicine & Life Sciences